XML 40 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets
   As of December 31, 
   2022   2021 
Deferred tax assets:          
Net operating losses  $151,433   $143,732 
Research and other credits   2,178    2,178 
Stock based compensation   4,087    3,354 
In-Process research and development   511    1,132 
Capitalized research and development costs   12,686    
-
 
Other   468    230 
Total deferred tax assets   171,363    150,626 
Valuation allowance   (171,363)   (150,626)
Net deferred tax assets  $
-
   $
-
 

 

Schedule of statutory tax rates and the effective tax rates
   Year Ended December 31, 
   2022   2021 
Statutory rate   21.0%   21.0%
Valuation allowance   (29.8)%   (28.5)%
Nondeductible stock compensation   1.9%   0.4%
Other   6.9%   7.1%
Effective tax rate   
-
%   
-
%

 

Schedule of unrecognized tax benefits
Balance at December 31, 2020  $1,060 
Additions based on tax positions related to prior year   
-
 
Additions based on tax positions related to current year   
-
 
Balance at December 31, 2021   1,060 
Additions based on tax positions related to prior year   
-
 
Additions based on tax positions related to current year   
-
 
Balance at December 31, 2022  $1,060